AzTrials
AzTrials

Family MembersNCT05284721

Family Peer Navigator for Early Psychosis for Black Families

A study testing Family Peer Navigator for Early Psychosis and Care Coordination in people with Family Members, run by Washington State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Family Members
What is being tested?
Family Peer Navigator for Early Psychosis and Care Coordination
Could I receive a placebo?
No, everyone receives an active treatment
How many people
36 participants
Where
1 siteUnited States
Study dates
1 Jan 2023to 30 Apr 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • ≥ 18 years of age
  • Identifies as Black/African American
  • Loved one who meets criteria for risk of psychosis with a total score of ≥ 3 on the Prodromal Questionnaire- Brief Version

Who cannot join

  • Family members who cannot understand the consent process
  • Non-English speaking adults
  • Black/African American families referred to coordinated specialty care and who have already been determined eligible for services by providers.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • New Journeys: Coordinated Specialty care

    Seattle, Washington, 98198

Other trials in United States

About this study

Official title: A Family Peer Navigator Model to Increase Access and Initial Engagement in Coordinated Specialty Care Programs Among Black Families

Building upon formative research, this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families.

Read the detailed description

The overall goal of this mixed methods study will be conducted in three phases to develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and engagement in coordinated specialty care programs among Black/African American families. Phase II will recruit 10 family member participants to complete a four-month open trial to refine the Family Peer Navigator model. During Phase III, a total of 40 Black/African American families will be recruited to participate in a randomized pilot trial of the Family Peer Navigator model against a low-intensive care coordination in two coordinated specialty care programs to assess acceptability, feasibility, and preliminary impact.

Conditions
Family Members
Being tested
Family Peer Navigator for Early Psychosis, Care Coordination
Keywords
Black/African American, Early Psychosis, Access and Engagement
Medical subject headings
Psychotic Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family Peer Navigator for Early PsychosisBehavioural

    The Family Peer Navigator model is theoretical underpinning by the Social-Ecological Model and the Social Cognitive Theory, that incorporates a mixture of evidence- and research-based strategies, to include three key components: 1) Introduction and Assessment; 2) Individual Psychoeducation; 3) Six Brief Check-In

  • Care CoordinationBehavioural

    active control, treatment as usual including services provided by the coordinated specialty care program for first-episode psychosis.

Study groups in NCT05284721
Study groupRoleWhat they receive
Care Coordination Phase IIIActive comparatorFamily member participants randomized to the active control will receive two brief psychoeducation sessions, two brief check ins across one month and linked to appropriate services.
Receives: Behavioral: Care Coordination
Family Peer Navigator model Psychosis Phase IIIExperimentalFamily member participants randomized to the Family Peer Navigator condition will participate in two sessions for introduction/assessment, four individual psychoeducation sessions, and six brief check ins delivered by Family Peer Navigators.
Receives: Behavioral: Family Peer Navigator for Early Psychosis

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Client Satisfaction Questionnaire-8 (CSQ-8)

    Self-report measure to assess acceptability, a brief measure for family member participant. Items are scored from 1 to 4. Possible total scores range from 8 to 32, with higher scores (>23) indicating greater satisfaction.

    Measured: Months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

  2. Youth Services Survey-Families (YSS-F)

    Self-report measure to assess acceptability in the following domains: appropriateness, participation, cultural sensitivity, social connectedness, and outcomes. Items in a domain are summed and divided by the total number of items, and scores greater than 3.5 are reported in the positive range for the domain.

    Measured: Baseline and Month 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

  3. Number of Referrals (Recruitment) to assess feasibility

    The number of family member participants recruited and referrals received categorized by where they originated.

    Measured: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

  4. Level of Engagement to measure feasibility

    Total number of sessions attended, the number of contact hours with families and by which method (videoconference, in person, text, email etc.) and the number of completed measures.

    Measured: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

  5. Rate of Retention to measure feasibility

    The percentage of families that drop out (family declined or missed 3 consecutive appointments).

    Measured: Baseline through study completion; repeated measure to assess change in feasibility through study completion, average of 4 months

Secondary outcomes (5)
  1. General Self-Efficacy scale

    A self report measure of self-efficacy correlated to emotion, optimism and work satisfaction. Scores range from 10 to 40 with higher scores indicating more self-efficacy.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  2. Youth Services Survey for Families - Social Connectedness Subscale

    Social connectedness will be measured using four questions (e.g., "I know people who will listen and understand me when I need to talk") from the YSS-F. Scores range from 4 to 20, higher scores indicating greater social connectedness.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  3. Culturally-adapted Knowledge about Psychosis questionnaire (CaKAP)

    Self-reported measure that includes 23 culturally specific items across five subscales: symptoms and problems relating to psychosis; cause; other treatments and services; course and outcome; and management. Total scores range from 0 through 104 where higher scores indicate greater knowledge.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  4. Youth Services Survey for Families - Cultural Sensitivity Subscale

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

  5. Scale to Assess Therapeutic Relationships in Community Mental Health Care (STAR)

    Measure includes 12-items to assess therapeutic relationships.

    Measured: Baseline through study completion; repeated measure to assess change through study completion, average of 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Mar 2022
  2. Study start1 Jan 2023
  3. Primary completion30 Apr 2026
  4. Study completion30 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
36 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05284721
Sponsor's protocol ID
19181-001
Status last verified
Jul 2026
First submitted
28 Feb 2022
Last updated
3 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Oluwoye O, Stokes BI, Burduli E, Kriegel LS, Hoagwood KE. Community-based family peer navigator programme to facilitate linkage to coordinated specialty care for early psychosis among Black families in the USA: A protocol for a hybrid type I feasibility study. BMJ Open. 2023 Jul 5;13(7):e075729. doi: 10.1136/bmjopen-2023-075729.

    PubMed 37407058

Questions about this trial

What is this clinical trial studying?

A study testing Family Peer Navigator for Early Psychosis and Care Coordination in people with Family Members, run by Washington State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Client Satisfaction Questionnaire-8 (CSQ-8) (time frame: Months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months). The study lists 5 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05284721, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in